Drug Trial Radar · NCT06006247
Early Parkinson's Disease Monotherapy With CVN424
Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Sep 11, 2023
Primary completion
Jan 30, 2025
Study completion Feb 13, 2025
Sponsor
- Lead sponsor
- Cerevance Beta, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, 12-week, placebo-controlled clinical trial of CVN424 150 milligrams (mg) tablets in early, untreated Parkinson's Disease (PD). Participants will be randomized in a 1:1 ratio to CVN424 150 mg or placebo at the Baseline Visit. The purpose of this study is to measure effect on motor features with CVN424 tablets compared to placebo in early, untreated PD and to evaluate the potential of CVN424 to improve motor and non-motor functions in participants with early PD who are not taking dopaminergic or anti-PD therapies.
Conditions
- Parkinson's Disease
Interventions
CVN424 150 mgDrug
Participants will receive 1 CVN424 tablet (150 mg) per day.
PlaceboDrug
Participants will receive 1 matching placebo tablet per day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 12 on the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II + Part IIITime frame: Baseline (Day 1) and Up to Week 12
Locations
42 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Barrow Neurological Institute
Phoenix, Arizona
St Joseph's Hospital and Medical Center
Phoenix, Arizona
Muhammad Ali Parkinson Center
Phoenix, Arizona
Movement Disorders Center of Arizona, LLC
Scottsdale, Arizona
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California
CenExel Rocky Mountain Clinical Research
Englewood, Colorado
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
SFM Clinical Research, LLC
Boca Raton, Florida
N1 Research LLC
Orlando, Florida
Parkinson's Disease Treatment Center of SWFL
Port Charlotte, Florida
University of South Florida Parkinson's Disease and Movement Disorders Center
Tampa, Florida
Augusta University
Augusta, Georgia
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky, Dept of Neurology Kentucky Neuroscience Institute Research
Lexington, Kentucky
University of Kentucky, Center for Clinical and Translational Sciences
Lexington, Kentucky
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan Hospital / Michigan Clinical Research Unit (MCRU) Cardiovascular Center
Ann Arbor, Michigan
University of Michigan Department of Neurology
Ann Arbor, Michigan
Quest Research Institute
Farmington Hills, Michigan
Struthers Parkinson's Center
Golden Valley, Minnesota
Albany Medical Center
Albany, New York
Parkinson's Research Centers of America - Long Island
Commack, New York
Weill Cornell Medicine
New York, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Duke University Medical Center
Durham, North Carolina
Riverhills Healthcare, Inc dba Riverhills Neuroscience
Cincinnati, Ohio
The Ohio State University Department of Neurology - Madden Center for Parkinson Disease and Other Movement Disorders
Columbus, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Martha Morehouse Medical Plaza
Columbus, Ohio
Oregon Health & Science University
Portland, Oregon
Veracity Neuroscience
Memphis, Tennessee
Horizon Clinical Research Group
Cypress, Texas
Texas Movement Disorder Specialists, PLLC
Georgetown, Texas
Gill Neuroscience
Houston, Texas
Central Texas Neurology Consultants
Round Rock, Texas
Inova Neurology - Fairfax
Fairfax, Virginia
Inova Fairfax Medical Campus
Falls Church, Virginia
EvergreenHealth Neuroscience Institute
Kirkland, Washington
EvergreenHealth Research Department
Kirkland, Washington
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.